MICRO HEALTHSYSTEMS INC
SC 13D, 1995-10-24
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: PRIMARY TREND FUND INC, 485BPOS, 1995-10-24
Next: PAINEWEBBER EQUITY TRUST GROWTH STOCK SERIES 15, 485B24E, 1995-10-24



<PAGE>   1
                                                           OMB APPROVAL 
                                                     OMB Number:  3235-0145
                                                     Expires:  October 31, 1997
                                                     Estimated average burden 
                                                     hours per responses...14.90


                                UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C.  20549


                                SCHEDULE 13D


                  UNDER THE SECURITIES EXCHANGE ACT OF 1934
                          (AMENDMENT NO._________)*


              US SerVis, Inc. (f/k/a MICRO Healthsystems, Inc.)
- -------------------------------------------------------------------------------
                               (Name of Issuer)

                                 Common Stock
- -------------------------------------------------------------------------------
                        (Title of Class of Securities)

                                 594842 10 6
                   ---------------------------------------
                                (CUSIP Number)

Karen C. Fanelli, Frontenac Company, 135 S. LaSalle St. Suite 3800 
                              Chicago, IL 60603
- -------------------------------------------------------------------------------
     (Name, Address and Telephone Number of Person Authorized to Receive
                         Notices and Communications)

                                   10/12/95
                   --------------------------------------
           (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.

Check the following box if a fee is being paid with the statement /X/.  (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission.  See Rule 13d-1(a) for other parties to whom copies are to
be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).



                                 Page 1 of 17
<PAGE>   2
                                 SCHEDULE 13D

CUSIP No.  594842 10 6                                       Page 2 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Frontenac VI Limited Partnership 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      WC

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      Delaware 

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             1,415,000
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               0
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    1,415,000
                          10  SHARED DISPOSITIVE POWER 
                                0

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000
12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%
14  TYPE OF REPORTING PERSON*
      PN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   3
                                 SCHEDULE 13D



CUSIP No.  594842 10 6                                       Page 3 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Frontenac Company, a general partnership 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      Illinois 

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             1,415,000
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               0
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    1,415,000
                          10  SHARED DISPOSITIVE POWER 
                                0
11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      PN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   4
                                 SCHEDULE 13D



CUSIP No. 594842 10 6                                        Page 4 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      James E. Cowie 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   5
                                 SCHEDULE 13D



CUSIP No. 594842 10 6                                        Page 5 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Martin J. Koldyke 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY            0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING              1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                   0
                          10  SHARED DISPOSITIVE POWER 
                               1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   6
                                 SCHEDULE 13D





CUSIP No.  594842 10 6                                       Page 6 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Rodney L. Goldstein 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   7
                                 SCHEDULE 13D




CUSIP No. 594842 10 6                                        Page 7 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Roger S. McEniry 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   8
                                 SCHEDULE 13D


CUSIP No.  594842 10 6                                       Page 8 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      James E. Crawford III

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   9
                                 SCHEDULE 13D



CUSIP No. 594842 10 6                                        Page 9 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Laura P. Pearl 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   10
                                 SCHEDULE 13D



CUSIP No. 594842 10 6                                       Page 10 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Paul D. Carbery 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.



<PAGE>   11
                                 SCHEDULE 13D


CUSIP No. 594842 10 6                                       Page 11 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      M. Laird Koldyke 

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      U.S.A.

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   12
                                 SCHEDULE 13D

CUSIP No. 594842 10 6                                       Page 12 of 17 Pages 

1   NAME OF REPORTING PERSON 
    S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 
      Darcy J. Moore

2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                   (a)  /X/
                                                                        (b)  / /

3   SEC USE ONLY 

4   SOURCE OF FUNDS*
      AF

5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED                
    PURSUANT TO ITEMS 2(d) or 2(e)                                           / /
                                                                     
6   CITIZENSHIP OR PLACE OF ORGANIZATION 
      Canada 

      NUMBER OF            7  SOLE VOTING POWER
SHARES BENEFICIALLY             0
      OWNED BY             8  SHARED VOTING POWER 
   EACH REPORTING               1,415,000
       PERSON              9  SOLE DISPOSITIVE POWER 
        WITH                    0
                          10  SHARED DISPOSITIVE POWER 
                                1,415,000

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 
      1,415,000

12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES 
    CERTAIN SHARES*                                                         / /

13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 
      22.4%

14  TYPE OF REPORTING PERSON*
      IN

                    *SEE INSTRUCTIONS BEFORE FILLING OUT!
         INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7     2 of 7
     (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.


<PAGE>   13
                                  SCHEDULE 13D


ITEM 1.  SECURITY AND ISSUER.

         Security:        Common Stock
         Issuer:          US SerVis, Inc. (f/k/a MICRO
                          Healthsystems, Inc.)
                          414 Eagle Rock Avenue
                          West Orange, New Jersey 07052

ITEM 2.  IDENTITY AND BACKGROUND.

<TABLE>
         <S>     <C>      <C>
         (a)     Name:    Frontenac VI Limited Partnership
                          Frontenac Company (general partner of Frontenac VI)
                          James E. Cowie (general partner of Frontenac Company)
                          Paul D. Carbery (general partner of Frontenac Company)
                          James E. Crawford, III (general partner of Frontenac Company)
                          Rodney L. Goldstein (general partner of Frontenac Company)
                          Martin J. Koldyke (general partner of Frontenac Company)
                          M. Laird Koldyke (general partner of Frontenac Company)
                          Roger S. McEniry (general partner of Frontenac Company)
                          Darcy J. Moore (general partner of Frontenac Company)
                          Laura P. Pearl (general partner of Frontenac Company)
</TABLE>

         (b)     Address:         135 S. LaSalle Street, Suite 3800
                                  Chicago, IL 60603

         (c)     Principal Business: Private Equity Investment Fund

         (d)     Criminal Convictions:             None

         (e)     Civil Adjudication of
                 Violation of Securities Laws:     None

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

         $5,000,000 investment in the Issuer on 10/12/95; funds obtained from
working capital of private equity investment fund.

ITEM 4.  PURPOSE OF TRANSACTION.

         Equity investment in US SerVis, Inc. The Issuer sought the proceeds of
the investment for working capital purposes.

         Except as set forth above, the Reporting Persons do not have any plans
or proposals which relate to or would result in:

         (a)     The acquisition by any person of additional securities of the
Issuer, or the disposition of securities of the Issuer;

         (b)     An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any of its subsidiaries;





                                 Page 13 of 17
<PAGE>   14

         (c)     A sale or transfer of a material amount of assets of the
Issuer or any of its subsidiaries;

         (d)     Any change in the present Board of Directors or management of
the Issuer, including any plans or proposals to change the number or term of
directors or to fill any existing vacancies on the Board;

         (e)     Any material change in the present capitalization or dividend
policy of the Issuer;

         (f)     Any other material change in the Issuer's business or
corporate structure;

         (g)     Changes in the Issuer's charter, by-laws or instruments
corresponding thereto or other actions which may impede the acquisition of
control of the Issuer by any person;

         (h)     Causing a class of securities of the Issuer to be delisted
from a national securities exchange or to cease to be authorized to be quoted
in an inter-dealer quotation system of a registered national securities
association;

         (i)     A class of equity securities of the Issuer becoming eligible
for termination of registration pursuant to Section 12(g)(4) of the Securities
Exchange Act of 1934; or

         (j)     Any action similar to any of those enumerated above.

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

         (a)     1,415,000 common share equivalents, representing 1,250,000
shares of common stock issuable upon conversion of Series A convertible
preferred stock and 165,000 common shares issuable upon exercise of warrants at
an exercise price of $3.50 per share. See Item 11 of each of pages 2-12 for the
amount and percent of beneficial ownership of each member of the group, and
footnote l below.

         (b)     See Item 7-10 of each of pages 2-12 for the voting and
dispositive power of each member of the group.

         (c)     During the past 60 days, the Reporting Person and members of
the group have only acquired shares of the Issuer in the single transaction
described in Item 3 above.

         (d)     N/A

         (e)     N/A

ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
         TO SECURITIES OF THE ISSUER.

                 Pursuant to the transaction described in Item 3, the Issuer
granted certain registration rights to the Reporting Person with respect to the
shares of Common Stock of the Issuer that may be acquired by the Reporting
Persons and identified in this Schedule 13D.

                 Pursuant to the transaction described in Item 3, the Issuer
granted preemptive rights to the Reporting Person to subscribe for a pro-rata
portion of any additional issuances by the company.

                 Except as set forth above, the Reporting Person has no
contracts, arrangements, understandings or relationships (legal or otherwise)
with any person with respect to any securities of the Issuer, including but not
limited to transfer or voting of any of the securities, finder's fees, joint
ventures, loan or option arrangements, puts or calls, guarantees of profits,
division of profits or loss, or the giving or withholding of proxies.





                                 Page 14 of 17
<PAGE>   15

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

         Not applicable.





- -------------------
         1       Frontenac VI Limited Partnership ("Frontenac VI") is the
                 beneficial and record holder of 1,415,000 common share
                 equivalents of the Issuer. Frontenac Company, as the general
                 partner of Frontenac VI, has the sole power to direct the vote
                 of and direct the disposition of the shares held by Frontenac
                 VI. Mr. Cowie, Mr. Carbery, Mr. Crawford, Mr. Goldstein, Mr.
                 Martin J. Koldyke, Mr. M. Laird Koldyke, Mr. McEniry, Ms.
                 Moore and Ms. Pearl are general partners of Frontenac Company,
                 with the shared power to indirectly direct the voting of and
                 the disposition of common share equivalents held by Frontenac
                 VI.





                                 Page 15 of 17
<PAGE>   16

                                   SIGNATURE

         After reasonable inquiry and the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date:  October 23, 1995




Frontenac VI Limited Partnership

By:      Frontenac Company,
         its general partner


By:      __________________________________
         a general partner




Frontenac Company


By:      __________________________________
         a general partner





                                 Page 16 of 17
<PAGE>   17


Schedule 13D of
Frontenac VI Limited Partnership, et al.



___________________________________________
Karen C. Fanelli, Under Power of Attorney for:
         James E. Cowie
         Paul D. Carbery
         James E. Crawford, III
         Rodney L. Goldstein
         Martin J. Koldyke
         M. Laird Koldyke
         Roger S. McEniry
         Darcy J. Moore
         Laura P. Pearl





                                 Page 17 of 17



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission